Reuters reports The former chief executive of Insys Therapeutics Inc is expected on Wednesday to plead guilty to participating in a scheme to pay doctors bribes in exchange for prescribing an addictive opioid medication. Michael Babich, who resigned as the Arizona-based drugmaker’s CEO in 2015, is scheduled to appear in federal court in Boston and plead guilty to conspiracy and mail fraud charges, according to court papers.
